Treatment options for atrial fibrillation in a 62-year-old man

Publication
Article
Cardiology Review® OnlineApril 2007
Volume 24
Issue 4

A 62-year-old man with paroxysmal atrial fibrillation (AF) presents to his physician’s office for a discussion of treatment options for his AF.

A 62-year-old man with paroxysmal atrial fibrillation (AF) presents to his physician’s office for a discussion of treatment options for his AF. He has no history of hypertension or other stroke risk factors, and echocardiography indicates normal left ventricular function and left atrial size. He is highly symptomatic during his AF episodes despite treatment with β blockers for rate control. He is prescribed amiodarone to maintain sinus rhythm. Should this patient also be prescribed an angiotensin-converting enzyme inhibitor or an angiotensin-receptor blocker to enhance the efficacy of rhythm control?

Related Videos
Video 2 - "Lessons from EXPLORER-HCM: Unveiling CMIs' Potential in oHCM Treatment "
Video 1 - "Novel Cardio Myosin Inhibitors Targeting Obstructive Hypertrophic Cardiomyopathy's Root Cause "
A panel of 5 cardiovascular experts
A panel of 5 cardiovascular experts
Heart Failure Treatment Outcomes and Contraindications
Patient Involvement in Advanced HF Treatment, with Ashley Malliett, DMSc, MPAS, PA-C
Tailoring Chest Pain Diagnostics to Patients, with Kyle Fortman, PA-C, MBA
Kyle Fortman, PA-C, MBA: Troponin and Heart Injury Risk Screening Recommendations
What Should the American Academy of Physician Associates Focus on in 2025?
The Rising Rate of Heat-Related Illness, with Janelle Bludhorn, PA-C
© 2024 MJH Life Sciences

All rights reserved.